Izumi T - Search Results

1

Primary peripheral T-cell lymphoma, not otherwise specified of the thyroid with autoimmune thyroiditis.

Yoshida N, Nishikori M, Izumi T, Imaizumi Y, Sawayama Y, Niino D, Tashima M, Hoshi S, Ohshima K, Shimoyama M, Seto M, Tsukasaki K. Yoshida N, et al. Among authors: izumi t. Br J Haematol. 2013 Apr;161(2):214-23. doi: 10.1111/bjh.12255. Epub 2013 Feb 21. Br J Haematol. 2013. PMID: 23432459 Free article. Clinical Trial.

2

Bendamustine plus rituximab for previously untreated patients with indolent B-cell non-Hodgkin lymphoma or mantle cell lymphoma: a multicenter Phase II clinical trial in Japan.

Ogura M, Ishizawa K, Maruyama D, Uike N, Ando K, Izutsu K, Terui Y, Imaizumi Y, Tsukasaki K, Suzuki K, Izumi T, Usuki K, Kinoshita T, Taniwaki M, Uoshima N, Suzumiya J, Kurosawa M, Nagai H, Uchida T, Fukuhara N, Choi I, Ohmachi K, Yamamoto G, Tobinai K; Japanese Bendamustine Lymphoma Study Group. Ogura M, et al. Among authors: izumi t. Int J Hematol. 2017 Apr;105(4):470-477. doi: 10.1007/s12185-016-2146-4. Epub 2016 Nov 29. Int J Hematol. 2017. PMID: 27900638 Clinical Trial.

3

Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.

Shimada K, Yamaguchi M, Atsuta Y, Matsue K, Sato K, Kusumoto S, Nagai H, Takizawa J, Fukuhara N, Nagafuji K, Miyazaki K, Ohtsuka E, Okamoto M, Sugita Y, Uchida T, Kayukawa S, Wake A, Ennishi D, Kondo Y, Izumi T, Kin Y, Tsukasaki K, Hashimoto D, Yuge M, Yanagisawa A, Kuwatsuka Y, Shimada S, Masaki Y, Niitsu N, Kiyoi H, Suzuki R, Tokunaga T, Nakamura S, Kinoshita T. Shimada K, et al. Among authors: izumi t. Lancet Oncol. 2020 Apr;21(4):593-602. doi: 10.1016/S1470-2045(20)30059-0. Epub 2020 Mar 11. Lancet Oncol. 2020. PMID: 32171071 Clinical Trial.

4

Cutaneous T-cell lymphoma with massive co-infiltration of polyclonal B cells.

Yagi H, Ogai M, Izumi T, Ebihara T, Sugiura M, Tokura Y, Takigawa M. Yagi H, et al. Among authors: izumi t. Br J Dermatol. 1994 Feb;130(2):226-30. doi: 10.1111/j.1365-2133.1994.tb02905.x. Br J Dermatol. 1994. PMID: 7510123

5

Ala601-Thr type dysplasminogenaemia genetically diagnosed in patients with retinochoroidal vascular disorders.

Murata M, Ooe A, Izumi T, Nakagawa M, Takahashi S, Ishikawa M, Mori K, Ichinose A. Murata M, et al. Among authors: izumi t. Br J Haematol. 1997 Nov;99(2):301-3. doi: 10.1046/j.1365-2141.1997.4103229.x. Br J Haematol. 1997. PMID: 9375744 Free article.

6

Arg260-Cys mutation in severe factor XIII deficiency: conformational change of the A subunit is predicted by molecular modelling and mechanics.

Ichinose A, Tsukamoto H, Izumi T, Yamazaki T, Togashi M, Takamatsu J, Saito H, Umeyama H. Ichinose A, et al. Among authors: izumi t. Br J Haematol. 1998 May;101(2):264-72. doi: 10.1046/j.1365-2141.1998.00698.x. Br J Haematol. 1998. PMID: 9609521 Free article.

7

Development of acute myeloblastic leukaemia in a case of aplastic anaemia treated with granulocyte colony-stimulating factor.

Izumi T, Muroi K, Takatoku M, Imagawa S, Hatake K, Miura Y. Izumi T, et al. Br J Haematol. 1994 Jul;87(3):666-8. doi: 10.1111/j.1365-2141.1994.tb08339.x. Br J Haematol. 1994. PMID: 7527651

8

Tretinoin induces bone marrow collagenous fibrosis in acute promyelocytic leukaemia: new adverse, but reversible effect.

Hatake K, Ohtsuki T, Uwai M, Takahashi H, Izumi T, Yoshida M, Kanai N, Saito K, Harigaya K, Miura Y. Hatake K, et al. Among authors: izumi t. Br J Haematol. 1996 Jun;93(3):646-9. doi: 10.1046/j.1365-2141.1996.d01-1708.x. Br J Haematol. 1996. PMID: 8652386

9

Successful treatment of primary cardiac lymphoma with monoclonal CD20 antibody (rituximab).

Nakagawa Y, Ikeda U, Hirose M, Ubukata S, Katsuki TA, Kaminishi Y, Saito T, Hironaka M, Izumi T, Shimada K. Nakagawa Y, et al. Among authors: izumi t. Circ J. 2004 Feb;68(2):172-3. doi: 10.1253/circj.68.172. Circ J. 2004. PMID: 14745155 Free article.

10

Prognostic impact of serum soluble interleukin-2 receptor level at diagnosis in elderly patients with diffuse large B-cell lymphoma treated with R-CHOP.

Umino K, Fujiwara SI, Minakata D, Yamamoto C, Meguro A, Matsuyama T, Sato K, Ohmine K, Izumi T, Muroi K, Kanda Y. Umino K, et al. Among authors: izumi t. Leuk Lymphoma. 2019 Mar;60(3):734-741. doi: 10.1080/10428194.2018.1504939. Epub 2018 Sep 6. Leuk Lymphoma. 2019. PMID: 30188236

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,282 results

Search Page

Filters